JUNCTION CITY, Kan., May 12, 2026 (GLOBE NEWSWIRE) -- InVitria, a global leader in chemically defined, animal-origin-free recombinant proteins for advanced therapy manufacturing, announced its participation in the American Society of Gene and Cell Therapy (ASGCT) 2026 Annual Meeting, taking…